Healthcare Realty Trust Inc is a healthcare facility real estate investment trust... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PDI | 14.30 | 0.17 | +1.20% |
| PIMCO Dynamic Income Fund | |||
| BSCY | 19.83 | 0.17 | +0.86% |
| Invesco BulletShares 2034 Corporate Bond ETF (BSCY) | |||
| ACGR | 70.52 | N/A | N/A |
| American Century Large Cap Growth ETF (ACGR) | |||
| JANP | 35.79 | -0.24 | -0.66% |
| PGIM S&P 500 Buffer 12 ETF - January (JANP) | |||
| GLDI | 136.00 | -2.92 | -2.10% |
| UBS AG ETRACS Gold Shares Covered Call ETNs due February 2, 2033 (GLDI) | |||
A.I.dvisor indicates that over the last year, HR has been closely correlated with FRT. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if HR jumps, then FRT could also see price increases.
| Ticker / NAME | Correlation To HR | 1D Price Change % |
|---|---|---|
| HR | 100% | +4.00% |
| HR (2 stocks) | 68% Closely correlated | +3.47% |
| Publishing: Books/Magazines (18 stocks) | 65% Loosely correlated | +2.88% |
| Consumer Services (219 stocks) | 30% Poorly correlated | +0.60% |
a real estate investment trust
Industry PublishingBooksMagazines
HR saw its Momentum Indicator move above the 0 level on October 16, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 93 similar instances where the indicator turned positive. In 55 of the 93 cases, the stock moved higher in the following days. The odds of a move higher are at 59%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where HR's RSI Oscillator exited the oversold zone, 13 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 42%.
The Moving Average Convergence Divergence (MACD) for HR just turned positive on October 13, 2026. Looking at past instances where HR's MACD turned positive, the stock continued to rise in 27 of 48 cases over the following month. The odds of a continued upward trend are 56%.
Following a +2.58% 3-day Advance, the price is estimated to grow further. Considering data from situations where HR advanced for three days, in 139 of 288 cases, the price rose further within the following month. The odds of a continued upward trend are 48%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 61%.
HR broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for HR entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 21 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.401) is normal, around the industry mean (3.090). HR has a moderately low P/E Ratio (-66.308) as compared to the industry average of (27.956). Projected Growth (PEG Ratio) (0.310) is also within normal values, averaging (1.649). Dividend Yield (0.056) settles around the average of (0.049) among similar stocks. P/S Ratio (5.757) is also within normal values, averaging (6.013).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 70 (best 1 - 100 worst), indicating slightly worse than average price growth. HR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 62, placing this stock worse than average.